Biochemical and Biophysical Research Communications
Therapeutic effects of α-iso-cubebenol, a natural compound isolated from the Schisandra chinensis fruit, against sepsis
Highlights
► α-Iso-cubebenol showed therapeutic effect against experimental sepsis. ► α-Iso-cubebenol enhanced the bactericidal effects of phagocytic cells. ► α-Iso-cubebenol reduced immune cell apoptosis. ► α-Iso-cubebenol significantly reduced the production of IL-1β in sepsis model. ► The finding suggests a novel therapeutic approach to treat polymicrobial sepsis.
Introduction
Sepsis, a systemic inflammatory response, is caused by viable bacteria or bacterial products such as lipopolysaccharide (LPS) [1]. More than 750,000 patients develop sepsis annually in the United States, and the incidence rate is gradually increasing [2]. The number of hospitalizations with sepsis in the US increased from 300,000 to around 800,000 from 2000 to 2007 [3]. Although the mortality rate of sepsis decreased somewhat from 2000 to 2007, sepsis remains the major cause of death in intensive care units, and the overall mortality associated with sepsis ranges from 30% to 70% [2]. Only 2% of hospitalizations are for sepsis, yet it makes up 17% of in-hospital deaths in the US [4]. Sepsis-induced lethality is accompanied by the failure of an appropriate immune response against invading pathogens [5], [6]. The inability of the innate immune system to respond during early sepsis (i.e., the first 6 h) results in increased mortality. Excessive lymphocyte apoptosis can occur during sepsis, which results in the clinical signs of multi-organ failure [7], [8]. Since sepsis is caused by viable bacteria or bacterial products, the levels of proinflammatory cytokines such as tumor necrosis factor (TNF) and interleukin (IL)-1β are substantially increased during sepsis [9], [10], [11]. Thus, an effective treatment for sepsis should control bacteria, prevent production of inflammatory cytokines, and block widespread leukocyte apoptosis.
We previously isolated a novel natural compound, α-iso-cubebenol, from the Schisandra chinensis fruit and demonstrated that the compound inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in lipopolysaccharide (LPS)-stimulated macrophages [12]. Subsequently, α-iso-cubebenol has been reported to induce heme oxygenase-1 expression and have anti-inflammatory activity in Porphyromonas gingivalis LPS-stimulated macrophages [13]. In this study we investigated the in vivo efficacy of α-iso-cubebenol in a preclinical mouse model of sepsis. We also examined the mechanisms of septic protection by this novel natural compound.
Section snippets
Purification of α-iso-cubebenol
α-Iso-cubebenol (CAS registry number: 1219105-52-8) was purified from the dried fruit of S. chinensis as described previously [12]. The fruit of S. chinensis (Turcz.) Baill was collected in September 2005 from Moonkyong, Korea. A voucher specimen (Accession No. SC-PDRL-1) has been deposited in the Herbarium of Pusan National University. The plant was identified by one of the authors (Y. Choi). The dried fruit of S. chinensis (2.5 kg) ground to a fine powder and then successively extracted at
α-Iso-cubebenol administration protects against sepsis-induced mortality
We first investigated whether α-iso-cubebenol, its chemical structure was shown in Fig. 1A, has anti-septic activity against polymicrobial sepsis using a CLP sepsis model. α-Iso-cubebenol administration strongly protected against mortality induced by CLP in a dose-dependent manner (Fig. 1B). Survival was strongly enhanced, reaching 80% when 15 mg/kg of α-iso-cubebenol was injected 2 h post-CLP and additionally three times at 12 h intervals (Fig. 1B). Inflammation of vital organs such as lung is
Discussion
With improvements in hospital care and increased awareness of deadly diseases, mortality rates from sepsis have decreased in recent years [3], [4]. However, 1 in 1200 Americans die of severe sepsis annually [3], [4]. Even though 17% of in-hospital deaths in the US are caused by sepsis, drugs that combat sepsis without antibiotics are not clinically available. Xigris, which had been approved by the US FDA as a therapeutic agent against sepsis, was withdrawn from the market. Thus, researchers are
Acknowledgments
This research was supported by Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (311054031HD120) and by National Research Foundation of Korea (NRF) Grants funded by the Korean government (MEST) (Nos. 2009 0093198, 35B-2011-1-E00012).
We thank Dr. Brian A. Zabel of Palo Alto Institute for Research and Education for helpful discussion.
SL, YC, and YB have pending patent applications. The other authors have no financial conflicts of interest.
References (21)
- et al.
Nationwide trends of severe sepsis in the 21st century (2000–2007)
Chest
(2011) - et al.
The ‘‘cytokine profile’’: a code for sepsis
Trends Mol. Med.
(2005) - et al.
Identification of a novel compound that inhibits iNOS and COX-2 expression in LPS-stimulated macrophages from Schisandra chinensis
Biochem. Biophys. Res. Commun.
(2010) - et al.
Schisandra chinensis α-iso-cubebenol induces heme oxygenase-1 expression through PI3K/Akt and Nrf2 signaling and has anti-inflammatory activity in Porphyromonas gingivalis lipopolysaccharide-stimulated macrophages
Int. Immunopharmacol.
(2011) - et al.
Inhibition of endothelial cell adhesion by the new anti-inflammatory agent alpha-iso-cubebene
Vascul. Pharmacol.
(2009) - et al.
Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1
Biochem. Pharmacol.
(2006) The immunopathogenesis of sepsis
Nature
(2002)- et al.
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
Crit. Care Med.
(2001) - et al.
Inpatient care for septicemia or sepsis: a challenge for patients and hospitals
NCHS Data Brief
(2011) - et al.
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment
Nat. Med.
(1997)
Cited by (14)
A new industrial model: The utilization of the traditional Chinese herb Schisandra chinensis (Turcz.) Baill. from soil to plate
2023, Industrial Crops and ProductsA review of polysaccharides from Schisandra chinensis and Schisandra sphenanthera: Properties, functions and applications
2018, Carbohydrate PolymersCitation Excerpt :Furthermore, long-term intake of Schisandra can relieve organ dysfunction, maintain good health, and enhance immunity. Recent pharmacological research demonstrated that Schisandra possesses more than forty types of beneficial components(Bae et al., 2012; Huyke, Engel, Simon-Haarhaus, Quirin, & Schempp, 2007), such as lignans (schisantherin A (Ci et al., 2010; Zhou et al., 2014), schisandrin A/B/C (Guo et al., 2009; Guo et al., 2008; Liu et al., 2015; Park, Park, Kim, Kim, Kim et al., 2011; Park et al., 2013; Song, Zeng et al., 2016; Zeng, Zhang, Fu, Liu, & Wang, 2012), gomisin A/N/G/J (Araki, Hiraki, Nishida, Inatomi, & Yabe, 2016; Jeong, Han, Kim, Choi, & Kim, 2014; Kim et al., 2008; Ryu et al., 2011; Wang et al., 2014), dibenzocyclooctadiene lignans (Hu, Han et al., 2014; Hu, Yang et al., 2014) and chicanine (Chen et al., 2014)) polysaccharides, organic acids, terpenoid volatile components (triterpenoids, α-isocubebenol (Kim et al., 2012; Lee et al., 2012; Lee et al., 2010; Park, Park, Kim, Kim, Choi et al., 2011), α-cubebenoate (Kang et al., 2014; Kook et al., 2015; Lee et al., 2015)), vitamins, and trace elements. These bioactive components can be extracted from the leaves (Xu et al., 2012), stems (Liu et al., 2017), roots (Jiang et al., 2015), and fruit (Huang, Lin, Chyau, Lin, & Chang, 2013).
Identification of a novel anti-inflammatory compound, α-cubebenoate from Schisandra chinensis
2014, Journal of EthnopharmacologyCitation Excerpt :α-Iso-cubebenol was found to be an anti-inflammatory agent against bacterial infections or endotoxin (Lee et al., 2010). In addition, α-iso-cubebenol strongly ameliorated the septic effects of cecal ligation and puncture challenge (Lee et al., 2012). α-Iso-cubebenol induced anti-septic activity was recently found to be mediated by CXCR2 (Jung et al., 2013), to induce p53-independent apoptosis in hepatocellular carcinoma cells (Kim et al., 2012a), and to suppress Aβ1-42 fibril-induced neuroinflammatory molecules in primary microglia by suppressing NF-κB/inhibitor of κBα and MAPK (Park et al., 2014).
Role of CXCR2 on the immune modulating activity of α-iso-cubebenol a natural compound isolated from the Schisandra chinensis fruit
2013, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Previously, we isolated a novel natural compound, α-iso-cubebenol, from the fruits of Schisandra chinensis and demonstrated that the compound shows therapeutic activity against cecal ligation and puncture (CLP) sepsis model [10,11]. Furthermore, α-iso-cubebenol strongly increased the survival rate in the CLP model by increasing the bactericidal activity of phagocytes, and by attenuating inflammatory cytokine production and blocking leukotycte apoptosis [11]. In this study, we investigated the in vitro activity of α-iso-cubebenol on neutrophil activity.
Active Ingredients of Schisandra chinensis Fruit Oil and their Effect on Propionibacterium acnes-Induced Inflammation in HaCaT Cells
2023, Frontiers in Bioscience - LandmarkIM156, a new AMPK activator, protects against polymicrobial sepsis
2022, Journal of Cellular and Molecular Medicine